Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A Chinese market matchup
May 2018
SHARING OPTIONS:

CAMBRIDGE, U.K. & SHENZHEN, China—Horizon Discovery Group plc and Genewell Biotechnology Limited have initiated a partnership under which Genewell will manufacture Horizon reference standards in China and distribute them as Research Use Only products for Chinese diagnostic companies. In addition, Genewell will seek approval with the Chinese Food and Drug Administration for the use of Horizon’s reference standards. Should the reference standards gain approval to be sold through Genewell’s customer base in China, Horizon will receive a royalty on all sales.
 
“As part of our global leadership strategy, Horizon has established the relationships and reputation needed to succeed in China. Our partnership with Genewell enables us to accelerate the process of bringing our high quality reference standards, both pre-existing and newly developed, to the whole of the Chinese market,” said Richard Vellacott, interim CEO and CFO, Horizon Discovery.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.